Countrywide management of pulmonary tuberculosis reverses increasing incidence.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationInt. J. Tuberc. Lung Dis. 2011, 15(7):892-8
AbstractOBJECTIVE: To evaluate the impact of countrywide management of tuberculosis (TB) and the availability of second-line drugs (SLDs) on the notification rates of pulmonary TB (PTB) overall and of multidrug-resistant TB (MDR-TB), taking into account human immunodeficiency virus (HIV) co-infection and the national economy in Estonia. DESIGN: Retrospective analysis of notification rates and treatment outcomes of PTB and MDR-TB during 1998-2006. RESULTS: The annual notification rates of both PTB and MDR-TB decreased significantly, by on average 3.3 (P = 0.007) and 1.7 (P = 0.008) cases per 100,000 population, respectively. The accelerating impact of SLD availability on the annual decline was significant for both PTB overall and MDR-TB (P = 0.003 and P = 0.025, respectively). During 1998-2006, an increase in TB-HIV co-infection (P = 0.009) significantly affected the notification rates of both PTB overall and MDR-TB (P < 0.001 and P < 0.001, respectively). The negative impact of TB-HIV co-infection was counterbalanced by the availability of SLDs, the decrease in the MDR-TB rate and the increase in gross domestic product (GDP) per capita, as confirmed by multivariate analysis. CONCLUSION: Countrywide access to SLDs and the coordinated effect of programmatic conditions can, in parallel with increasing GDP, reverse the increasing notification rates of PTB and MDR-TB in the context of an HIV epidemic.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field.
RightsArchived with thanks to The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
- High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia.
- Authors: Jugheli L, Rigouts L, Shamputa IC, Bram de Rijk W, Portaels F
- Issue date: 2008 May
- Predictors and mortality associated with treatment default in pulmonary tuberculosis.
- Authors: Kliiman K, Altraja A
- Issue date: 2010 Apr
- Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
- Authors: Mannheimer SB, Sepkowitz KA, Stoeckle M, Friedman CR, Hafner A, Riley LW
- Issue date: 1997 Aug
- HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
- Authors: Palacios E, Franke M, Muñoz M, Hurtado R, Dallman R, Chalco K, Guerra D, Mestanza L, Llaro K, Bonilla C, Sebastian J, Bayona J, Lygizos M, Anger H, Shin S
- Issue date: 2012
- Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
- Authors: Reechaipichitkul W
- Issue date: 2002 Sep